vs

Side-by-side financial comparison of CAPRICOR THERAPEUTICS, INC. (CAPR) and Pathfinder Bancorp, Inc. (PBHC). Click either name above to swap in a different company.

Pathfinder Bancorp, Inc. is the larger business by last-quarter revenue ($11.8M vs $11.1M, roughly 1.1× CAPRICOR THERAPEUTICS, INC.). Pathfinder Bancorp, Inc. runs the higher net margin — -52.9% vs -63.9%, a 11.0% gap on every dollar of revenue. On growth, CAPRICOR THERAPEUTICS, INC. posted the faster year-over-year revenue change (-7.9% vs -22.6%). Pathfinder Bancorp, Inc. produced more free cash flow last quarter ($10.4M vs $-15.3M). Over the past eight quarters, CAPRICOR THERAPEUTICS, INC.'s revenue compounded faster (93.0% CAGR vs 3.0%).

Capricor Therapeutics is a clinical-stage biotechnology company focused on discovering, developing and commercializing innovative biological therapies including cell and gene therapies for rare diseases, cardiovascular disorders and muscular conditions. It primarily operates in the U.S. market, addressing unmet medical needs for patient groups with limited treatment options.

Pathfinder Bancorp, Inc. is a regional bank holding company headquartered in New York, U.S. It operates Pathfinder Bank serving the central New York market, offering retail and commercial banking services including deposit accounts, mortgages, business loans and wealth management for individual consumers and small to medium-sized enterprises.

CAPR vs PBHC — Head-to-Head

Bigger by revenue
PBHC
PBHC
1.1× larger
PBHC
$11.8M
$11.1M
CAPR
Growing faster (revenue YoY)
CAPR
CAPR
+14.7% gap
CAPR
-7.9%
-22.6%
PBHC
Higher net margin
PBHC
PBHC
11.0% more per $
PBHC
-52.9%
-63.9%
CAPR
More free cash flow
PBHC
PBHC
$25.7M more FCF
PBHC
$10.4M
$-15.3M
CAPR
Faster 2-yr revenue CAGR
CAPR
CAPR
Annualised
CAPR
93.0%
3.0%
PBHC

Income Statement — Q4 FY2024 vs Q4 FY2025

Metric
CAPR
CAPR
PBHC
PBHC
Revenue
$11.1M
$11.8M
Net Profit
$-7.1M
$-5.6M
Gross Margin
Operating Margin
-69.1%
-81.1%
Net Margin
-63.9%
-52.9%
Revenue YoY
-7.9%
-22.6%
Net Profit YoY
-833.8%
-242.4%
EPS (diluted)
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CAPR
CAPR
PBHC
PBHC
Q4 25
$11.8M
Q3 25
$13.1M
Q2 25
$9.3M
Q1 25
$12.6M
Q4 24
$11.1M
$15.3M
Q3 24
$2.3M
$13.4M
Q2 24
$4.0M
$10.7M
Q1 24
$4.9M
$11.1M
Net Profit
CAPR
CAPR
PBHC
PBHC
Q4 25
$-5.6M
Q3 25
$626.0K
Q2 25
$31.0K
Q1 25
$3.0M
Q4 24
$-7.1M
$3.9M
Q3 24
$-12.6M
$-4.6M
Q2 24
$-11.0M
$2.0M
Q1 24
$-9.8M
$2.1M
Operating Margin
CAPR
CAPR
PBHC
PBHC
Q4 25
-81.1%
Q3 25
5.1%
Q2 25
0.4%
Q1 25
29.5%
Q4 24
-69.1%
55.4%
Q3 24
-575.2%
-43.1%
Q2 24
-291.9%
23.3%
Q1 24
-209.2%
24.3%
Net Margin
CAPR
CAPR
PBHC
PBHC
Q4 25
-52.9%
Q3 25
4.8%
Q2 25
0.3%
Q1 25
23.6%
Q4 24
-63.9%
37.7%
Q3 24
-555.2%
-34.6%
Q2 24
-277.0%
18.7%
Q1 24
-199.6%
19.0%
EPS (diluted)
CAPR
CAPR
PBHC
PBHC
Q4 25
Q3 25
$0.47
Q2 25
$0.47
Q1 25
Q4 24
$-0.11
Q3 24
$-0.38
$0.41
Q2 24
$-0.35
$0.41
Q1 24
$-0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CAPR
CAPR
PBHC
PBHC
Cash + ST InvestmentsLiquidity on hand
$151.5M
Total DebtLower is stronger
$14.1M
Stockholders' EquityBook value
$145.5M
$122.5M
Total Assets
$170.5M
$1.4B
Debt / EquityLower = less leverage
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CAPR
CAPR
PBHC
PBHC
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$151.5M
Q3 24
$85.0M
Q2 24
$29.5M
Q1 24
$39.9M
Total Debt
CAPR
CAPR
PBHC
PBHC
Q4 25
$14.1M
Q3 25
$18.7M
Q2 25
$21.0M
Q1 25
$17.6M
Q4 24
$27.1M
Q3 24
$39.8M
Q2 24
$45.9M
Q1 24
$45.9M
Stockholders' Equity
CAPR
CAPR
PBHC
PBHC
Q4 25
$122.5M
Q3 25
$126.3M
Q2 25
$124.4M
Q1 25
$124.9M
Q4 24
$145.5M
$121.5M
Q3 24
$68.3M
$120.2M
Q2 24
$11.5M
$123.3M
Q1 24
$18.4M
$121.8M
Total Assets
CAPR
CAPR
PBHC
PBHC
Q4 25
$1.4B
Q3 25
$1.5B
Q2 25
$1.5B
Q1 25
$1.5B
Q4 24
$170.5M
$1.5B
Q3 24
$93.0M
$1.5B
Q2 24
$38.3M
$1.4B
Q1 24
$49.4M
$1.5B
Debt / Equity
CAPR
CAPR
PBHC
PBHC
Q4 25
0.11×
Q3 25
0.15×
Q2 25
0.17×
Q1 25
0.14×
Q4 24
0.22×
Q3 24
0.33×
Q2 24
0.37×
Q1 24
0.38×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CAPR
CAPR
PBHC
PBHC
Operating Cash FlowLast quarter
$-14.8M
$11.7M
Free Cash FlowOCF − Capex
$-15.3M
$10.4M
FCF MarginFCF / Revenue
-137.3%
88.1%
Capex IntensityCapex / Revenue
4.4%
10.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-41.2M
$18.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CAPR
CAPR
PBHC
PBHC
Q4 25
$11.7M
Q3 25
$7.0M
Q2 25
$-3.7M
Q1 25
$5.7M
Q4 24
$-14.8M
$11.2M
Q3 24
$-11.6M
$11.8M
Q2 24
$-12.3M
$1.5M
Q1 24
$-1.3M
$504.0K
Free Cash Flow
CAPR
CAPR
PBHC
PBHC
Q4 25
$10.4M
Q3 25
$6.9M
Q2 25
$-4.0M
Q1 25
$5.1M
Q4 24
$-15.3M
$9.1M
Q3 24
$-11.7M
$11.3M
Q2 24
$-12.3M
$637.0K
Q1 24
$-1.9M
$274.0K
FCF Margin
CAPR
CAPR
PBHC
PBHC
Q4 25
88.1%
Q3 25
52.8%
Q2 25
-42.6%
Q1 25
40.1%
Q4 24
-137.3%
59.9%
Q3 24
-515.2%
84.3%
Q2 24
-310.9%
6.0%
Q1 24
-38.3%
2.5%
Capex Intensity
CAPR
CAPR
PBHC
PBHC
Q4 25
10.7%
Q3 25
1.0%
Q2 25
2.4%
Q1 25
5.1%
Q4 24
4.4%
13.5%
Q3 24
0.4%
3.8%
Q2 24
1.5%
8.2%
Q1 24
12.4%
2.1%
Cash Conversion
CAPR
CAPR
PBHC
PBHC
Q4 25
Q3 25
11.26×
Q2 25
-120.55×
Q1 25
1.92×
Q4 24
2.87×
Q3 24
Q2 24
0.76×
Q1 24
0.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CAPR
CAPR

Segment breakdown not available.

PBHC
PBHC

Other$5.6M47%
Banking$3.7M31%
Deposit Account$1.5M13%
Financial Service Other$1.0M9%

Related Comparisons